CCND2 and neoplasm: A study based on miR-26a replacement by using AAV as delivery vector potently suppresses cancer cell proliferation and activates tumor-specific apoptosis in vivo, leading to dramatic suppression of tumor progression without toxicity, as miR-26a induces a G1 arrest in human liver cancer cells by downregulating cyclins D2 and E2 [70].